Clinical trial

Impact GLP-1 Agonists Following Bariatric

NCT06132477

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-02-01

PhasePHASE4

Study timeline

Study start (actual)2024-02-01Date precision: day

Registry last updated2026-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Morbid Obesityunresolved

Metabolic Syndromeunresolved

Diabetes Mellitusunresolved

Hypertensionunresolved

Obstructive Sleep Apnea of Adultunresolved

Interventions

GLP-1 receptor agonistDRUG

Sponsors & collaborators

University of Missouri-Columbialead sponsor

American Society for Metabolic and Bariatric Surgerycollaborator

Mapped research locations

ColumbiaMissouri, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06132477 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.